Home Industries Market Insights About Us Publisher Contact us

Interventional Oncology Devices Market By Product Type (Radio-embolic agents, Non-radioactive embolic agents, Tumor ablation) By End User (Liver Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, Kidney Cancer, Bone Metastasis) - Global Opportunity Analysis And Industry Forecast, 2021-2027

Categories: Life Science

Formate :

Global Interventional Oncology Devices Market Overview

The Global Interventional Oncology Devices Market size is estimated to reach $1,538.1 Million by 2026, growing at a CAGR of 6.4% over the forecast period of 2021-2026. Interventional oncology is a branch of interventional radiology that focuses on detecting and treating cancer and cancer-related disorders utilizing image-guided minimally invasive techniques.

Interventional oncology is a branch of modern oncology that uses X-ray, ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) to guide miniaturized instruments (such as biopsy needles, ablation electrodes, and intravascular catheters) to treat solid tumors with pinpoint accuracy. The acceptance of interventional oncology is being driven by a growing demand for less invasive treatment techniques, increased cancer incidence, an increase in hospitals, and technical breakthroughs in radiology in many nations worldwide.

 

Impact of COVID-19 on Interventional Oncology Devices Market

The expansion of the interventional oncology devices market was hampered during COVID-19, particularly in 2020. Even though the interventional oncology clinics continued to function, the firms' revenues suffered a setback.

 

Key Takeaways from Global Interventional Oncology Devices Market Report:

·          Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for a product, end-use, technology, applications and by different industry verticals. Understand the market dynamics – key driving factors, challenges, and hidden opportunities.

·          Get in-depth insights on your competitor's performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

·          Analyze the sales and distribution channels across key geographies to improve top-line revenues.

·          Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes.

·          Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past 4 years.

·          Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than the top 20 countries globally for the market.

 

 By product, the radio-embolic agent sector is estimated to grow at the highest CAGR during the forecast period.

Radio-embolic agent-related procedures commanded the largest share of the global interventional oncology market in 2020, mainly due to their wide usage with high sensitivity, specificity, and accuracy towards the detection and characterization of tumors. They also have greater usage. It is also the fastest-growing over 2021-2026, with a CAGR of 6.9%.

 

By application, liver cancer held the largest share during the forecast period.

The greatest proportion of the worldwide interventional oncology market went to liver cancer, owing to the availability of a wide range of embolization and ablation devices for liver cancer therapy and the disease's rising prevalence and mortality. Furthermore, during the forecast period, this segment is expected to grow at the fastest CAGR of 6.9% due to rising disease diagnosis and treatment rates, growing awareness about the fatality and benefits of early diagnosis and treatment across the globe, and growing access to innovative products and their increasing reimbursement coverage.

 

The Asia Pacific to account for the largest market share during the forecast period

The interventional oncology market in North America was the largest globally, with a share of 36.9% in 2020. However, because of the faster economic expansion of several nations in the area and a growing government focus on the healthcare sector, Asia-Pacific will be the fastest expanding regional market. Furthermore, government initiatives to develop healthcare facilities, rising cancer incidence and prevalence, rising awareness of overall health and treatment availability, growing middle-class population and their level of disposable income, increasing health insurance penetration, and the region's aging population are all driving the Asia-Pacific interventional oncology market forward.

 

Market Dynamics

Driver: Rising cases of cancer in the world is a key driver in Interventional Oncology Devices Market

Cancer is the second most common cause of mortality worldwide, accounting for 9.6 million fatalities in 2018. Cancer kills over 70% of people in low- and middle-income nations. The key causes of increased cancer mortality worldwide are late-stage diagnosis and unavailable therapy. According to the WHO, pathology services were typically provided in just 26% of low-income countries in the public sector in 2017. Treatment services were found to be available in more than 90% of high-income nations.

 

Challenge: Financial burden of product recalls has posed a major restraint in the Interventional Oncology Devices market

Many companies face product recalls from the market as a big challenge in this field. It is adding to the financial difficulties of these companies. Due to a lack of clinical data and an increase in the number of major adverse effects associated with the use of interventional oncology devices, multiple Product recalls have occurred, severely impeding the growth of the interventional oncology devices market.

 

Key Market Players  

Key Players in Global Interventional Oncology Devices Market consist of Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd.

 

Developments

There have been no developments in the Interventional Oncology Devices Market in the last 5 years.


Report Coverage and Scope

The report "Global Interventional Oncology Devices Market" by Research Informatic covers an in-depth detailed analysis for the following segment covered under the scope.

 

By Product

·          Radio-embolic agents

·          Non-radioactive embolic agents

·          Tumor ablation

 

By Applications

·          Liver Cancer

·          Lung Cancer

·          Breast Cancer

·          Prostate Cancer

·          Kidney Cancer

·          Bone Metastasis

 

Geography

·          North America

·          Europe

·          APAC

·          RoW

 

 

 Chapter 1 Interventional Oncology Devices Market Overview


1.1 Product Overview and Scope of Interventional Oncology Devices


1.2 Interventional Oncology Devices Market Segmentation By Product Type


1.2.1 Radio-embolic agents


1.2.2 Non-radioactive embolic agents


1.2.3 Tumor ablation


1.3 Interventional Oncology Devices Market Segmentation By Applications


1.3.1 Liver Cancer


1.3.2 Lung Cancer


1.3.3 Breast Cancer


1.3.4 Prostate Cancer


1.3.5 Kidney Cancer


1.3.6 Bone Metastasis


1.4 Interventional Oncology Devices Market Segmentation by Regions


1.4.1 North America


1.4.2 China


1.4.3 Europe


1.4.4 Southeast Asia


1.4.5 Japan


1.4.6 India


1.5 Global Market Size (Value) of Interventional Oncology Devices (2015-2027)


 


Chapter 2 Global Economic Impact on Interventional Oncology Devices Industry


2.1 Global Macroeconomic Environment Analysis


2.1.1 Global Macroeconomic Analysis


2.1.2 Global Macroeconomic Environment Development Trend


2.2 Global Macroeconomic Environment Analysis by Regions


 


Chapter 3 Global Interventional Oncology Devices Market Competition by Manufacturers


3.1 Global Interventional Oncology Devices Production and Share by Manufacturers (2021 and 2021)


3.2 Global Interventional Oncology Devices Revenue and Share by Manufacturers (2021 and 2021)


3.3 Global Interventional Oncology Devices Average Price by Manufacturers (2021 and 2021)


3.4 Manufacturers Interventional Oncology Devices Manufacturing Base Distribution, Production Area and Product Type


3.5 Interventional Oncology Devices Market Competitive Situation and Trends


3.5.1 Interventional Oncology Devices Market Concentration Rate


3.5.2 Interventional Oncology Devices Market Share of Top 3 and Top 5 Manufacturers


3.5.3 Mergers & Acquisitions, Expansion


 


Chapter 4 Global Interventional Oncology Devices Production, Revenue (Value) by Region (2015-2021)


4.1 Global Interventional Oncology Devices Production by Region (2015-2021)


4.2 Global Interventional Oncology Devices Production Market Share by Region (2015-2021)


4.3 Global Interventional Oncology Devices Revenue (Value) and Market Share by Region (2015-2021)


4.4 Global Interventional Oncology Devices Production, Revenue, Price and Gross Margin (2015-2021)


4.5 North America Interventional Oncology Devices Production, Revenue, Price and Gross Margin (2015-2021)


4.6 Europe Interventional Oncology Devices Production, Revenue, Price and Gross Margin (2015-2021)


4.7 China Interventional Oncology Devices Production, Revenue, Price and Gross Margin (2015-2021)


4.8 Japan Interventional Oncology Devices Production, Revenue, Price and Gross Margin (2015-2021)


4.9 Southeast Asia Interventional Oncology Devices Production, Revenue, Price and Gross Margin (2015-2021)


4.10 India Interventional Oncology Devices Production, Revenue, Price and Gross Margin (2015-2021)


 


Chapter 5 Global Interventional Oncology Devices Supply (Production), Consumption, Export, Import by Regions (2015-2021)


5.1 Global Interventional Oncology Devices Consumption by Regions (2015-2021)


5.2 North America Interventional Oncology Devices Production, Consumption, Export, Import by Regions (2015-2021)


5.3 Europe Interventional Oncology Devices Production, Consumption, Export, Import by Regions (2015-2021)


5.4 China Interventional Oncology Devices Production, Consumption, Export, Import by Regions (2015-2021)


5.5 Japan Interventional Oncology Devices Production, Consumption, Export, Import by Regions (2015-2021)


5.6 Southeast Asia Interventional Oncology Devices Production, Consumption, Export, Import by Regions (2015-2021)


5.7 India Interventional Oncology Devices Production, Consumption, Export, Import by Regions (2015-2021)


 


Chapter 6 Global Interventional Oncology Devices Production, Revenue (Value), Price Trend by Type


6.1 Global Interventional Oncology Devices Production and Market Share by Type (2015-2021)


6.2 Global Interventional Oncology Devices Revenue and Market Share by Type (2015-2021)


6.3 Global Interventional Oncology Devices Price by Type (2015-2021)


6.4 Global Interventional Oncology Devices Production Growth by Type (2015-2021)


 


Chapter 7 Global Interventional Oncology Devices Market Analysis by Application


7.1 Global Interventional Oncology Devices Consumption and Market Share by Application (2015-2021)


7.2 Global Interventional Oncology Devices Consumption Growth Rate by Application (2015-2021)


7.3 Market Drivers and Opportunities


7.3.1 Potential Applications


7.3.2 Emerging Markets/Countries


 


Chapter 8 Interventional Oncology Devices Manufacturing Cost Analysis


8.1 Interventional Oncology Devices Key Raw Materials Analysis


8.1.1 Key Raw Materials


8.1.2 Price Trend of Key Raw Materials


8.1.3 Key Suppliers of Raw Materials


8.1.4 Market Concentration Rate of Raw Materials


8.2 Proportion of Manufacturing Cost Structure


8.2.1 Raw Materials


8.2.2 Labour Cost


8.2.3 Manufacturing Expenses


8.3 Manufacturing Process Analysis of Interventional Oncology Devices 


 


Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers


9.1 Interventional Oncology Devices Industrial Chain Analysis


9.2 Upstream Raw Materials Sourcing


9.3 Raw Materials Sources of Interventional Oncology Devices Major Manufacturers in 2021


9.4 Downstream Buyers


 


Chapter 10 Marketing Strategy Analysis, Distributors/Traders


10.1 Marketing Channel


10.1.1 Direct Marketing


10.1.2 Indirect Marketing


10.1.3 Marketing Channel Development Trend


10.2 Market Positioning


10.2.1 Pricing Strategy


10.2.2 Brand Strategy


10.2.3 Target Client


10.3 Distributors/Traders List


 


Chapter 11 Market Effect Factors Analysis


11.1 Technology Progress/Risk


11.1.1 Substitutes Threat


11.1.2 Technology Progress in Related Industry


11.2 Consumer Needs/Customer Preference Change


11.3 Economic/Political Environmental Change


 


Chapter 12 Global Interventional Oncology Devices Market Forecast (2021-2027)


12.1 Global Interventional Oncology Devices Production, Revenue Forecast (2021-2027)


12.2 Global Interventional Oncology Devices Production, Consumption Forecast by Regions (2021-2027)


12.3 Global Interventional Oncology Devices Production Forecast by Type (2021-2027)


12.4 Global Interventional Oncology Devices Consumption Forecast by Application (2021-2027)


12.5 Interventional Oncology Devices Price Forecast (2021-2027)


 


Chapter 13 Appendix    


 


 


 

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is Interventional Oncology?

Interventional oncology is a branch of interventional radiology that focuses on detecting and treating cancer and cancer-related disorders utilizing image-guided minimally invasive techniques.

What is the Interventional Oncology Devices market share?

The Global Interventional Oncology Devices Market size is estimated to reach $1,538.1 Million by 2026, growing at a CAGR of 6.4% over the forecast period of 2021-2026.

What are the key factors driving the Interventional Oncology Devices Market?

Rising cases of cancer in the world is a key driver in Interventional Oncology Devices Market. Cancer is the second most common cause of mortality worldwide, accounting for 9.6 million fatalities in 2018. Cancer kills over 70% of people in low- and middle-income nations.

What are the top companies in the Interventional Oncology Devices Market?

Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd.

In which Region the market is growing?

The interventional oncology market in North America was the largest globally, with a share of 36.9% in 2020.

Which is the top product segment in the Interventional Oncology Devices market?

By product, the radio-embolic agent sector is estimated to grow at the highest CAGR during the forecast period.

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Interventional Oncology Devices Market By Product ...

RD Code : HP21